(20,000) (43,000)
(Decrease) increase in accounts
payable and accrued expenses (1,505,000) 1,645,000
Increase (decrease) in
income taxes payable 681,000 (903,000)
------- -------
Net Cash provided by Operating
Activities 1,718,000 2,018,000
--------- ---------
Cash Flows From Investing Activities:
Purchase of equipment and
leasehold improvements (269,000) (3,130,000)
------- ---------
Net Cash used in Investing Activities (269,000) (3,130,000)
------- ---------
Cash Flows from Financing Activities:
Principal payments of patent
deferred payable (45,000) (196,000)
Net (payments) borrowing on
Line of Credit (2,000,000) 1,700,000
Principal (payments) on Term Note (396,000) (250,000)
Net Principal borrowing on TI Loan 1,767,000 -
Principal payments on Real Estate Loan (31,000) (28,000)
Stock Repurchases (137,000) -
------- ---
Net Cash (used in) provided by
Financing Activities (842,000) 1,226,000
------- ---------
Net increase in Cash and Cash
Equivalents 607,000 114,000
Cash and Cash Equivalents,
beginning of year 517,000 403,000
-
'/>"/>SOURCE Pro-Dex, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related medicine news :1.
Pro-Dex, Inc. Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast2.
Pro-Dex, Inc. Announces Fiscal 2009 Third Quarter Financial Results Conference Call and Webcast3.
Pro-Dex, Inc. Announces Fiscal 2008 Third Quarter Financial Results Conference Call and Webcast4.
Pro-Dex, Inc. Provides Updates on Key Developments5.
American Pacific Announces Executive Change6.
United Way of Greater Los Angeles Announces Matching Fund Launched by Two Local Philanthropists7.
Satellite Healthcare Announces the Recipients of the 2009 Norman S. Coplon Extramural Grants8.
AAF(R) Announces MEGAcel(TM) I Filter with Helior(TM) Media9.
SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test10.
Neogen Corporation Announces 1st Quarter Results Conference Call11.
MDS Announces CEO Transition Plan